alitretinoin

alitretinoin information and resources from the National Cancer Institute

Panretin

Topical treatment of cutaneous lesions in patients with AIDS-related Kaposi's sarcoma.

Ligand Pharmaceuticals Feb 02 1999

(PZ) Basilea Pharmaceutica Ltd. Shareholders Approve All Board of ... Mar 28, 2006
Houston Chronicle, This year we look forward to news on the initiation of our antifungal, BAL8557 phase III trails, anticipate phase III results on alitretinoin and further ...

(PZ) Basilea Pharmaceutica Ltd. Reports 2005 Financial Results Feb 27, 2006
Houston Chronicle, ...announced positive phase II trial results on our novel broad-spectrum antifungal drug BAL8557 and our international phase III alitretinoin registration trial ...

Basilea announces positive phase III results for ceftobiprole, its ... Mar 2, 2006
PharmaLive.com (press release), About Alitretinoin (BAL4079) Alitretinoin is a novel vitamin A analog that is developed for patients with chronic hand eczema that is refractory to ...

alitretinoin -->

Home | About | Search topics | Cancers | Treatment | Medications
Onconews provides free news and resources on cancer-related topics.

Copyright onconews.org 2005-2006.
All Rights Reserved.
Google
 
Web onconews.org